Sample Request

Global Bispecific Antibody Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)

SELECT LICENSE:

Published on 08/27/2020| Code: MAR41115D| Category: Utilities| Total Pages: 122

The Bispecific Antibody market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Bispecific Antibody market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Bispecific Antibody market. The report focuses on well-known providers in the global Bispecific Antibody industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Bispecific Antibody Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Bispecific Antibody market covered in Chapter 4:

Jounce Therapeutics
Affimed Therapeutics
Genmab
EMD Serono
Regeneron Pharmaceuticals
Roche
Chugai Pharmaceutical
Sanofi
Immunomedics
Neovii Biotech
Eli Lilly
Amgen
Pieris
Merus
Ablynx
Genentech
OncoMed Pharmaceuticals
MacroGenics
NovImmune SA
Adimab
Emergent BioSolutions
AstraZeneca (MedImmune)

In Chapter 11 and 13.3, on the basis of types, the Bispecific Antibody market from 2015 to 2026 is primarily split into:

Catumaxomab (Removab)
Blinatumomab
Duligotumab
SAR 156597

In Chapter 12 and 13.4, on the basis of applications, the Bispecific Antibody market from 2015 to 2026 covers:

BsMAb for Diagnosis of Infectious Diseases
Diagnosis of Bacterial Infections
Diagnosis of Viral Infections
BsMAb for Cancer Diagnostic
BsAbs Blocking Signaling Pathways
BsAbs Targeting Tumor Angiogenesis
Specific Delivery of Effector Compounds to Targets
Bispecific Antibodies & Gene Therapy

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global Bispecific Antibody Market Share by Type (2020-2026)

1.5.2 Catumaxomab (Removab)
1.5.3 Blinatumomab
1.5.4 Duligotumab
1.5.5 SAR 156597
1.6 Market by Application

1.6.1 Global Bispecific Antibody Market Share by Application (2020-2026)

1.6.2 BsMAb for Diagnosis of Infectious Diseases
1.6.3 Diagnosis of Bacterial Infections
1.6.4 Diagnosis of Viral Infections
1.6.5 BsMAb for Cancer Diagnostic
1.6.6 BsAbs Blocking Signaling Pathways
1.6.7 BsAbs Targeting Tumor Angiogenesis
1.6.8 Specific Delivery of Effector Compounds to Targets
1.6.9 Bispecific Antibodies & Gene Therapy
1.7 Bispecific Antibody Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on Bispecific Antibody Industry Development

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 Porter’s Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

3 Value Chain of Bispecific Antibody Market

3.1 Value Chain Status

3.2 Bispecific Antibody Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of Bispecific Antibody

3.2.3 Labor Cost of Bispecific Antibody

3.2.3.1 Labor Cost of Bispecific Antibody Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

4 Players Profiles

4.1 Jounce Therapeutics
4.1.1 Jounce Therapeutics Basic Information
4.1.2 Bispecific Antibody Product Profiles, Application and Specification
4.1.3 Jounce Therapeutics Bispecific Antibody Market Performance (2015-2020)
4.1.4 Jounce Therapeutics Business Overview
4.2 Affimed Therapeutics
4.2.1 Affimed Therapeutics Basic Information
4.2.2 Bispecific Antibody Product Profiles, Application and Specification
4.2.3 Affimed Therapeutics Bispecific Antibody Market Performance (2015-2020)
4.2.4 Affimed Therapeutics Business Overview
4.3 Genmab
4.3.1 Genmab Basic Information
4.3.2 Bispecific Antibody Product Profiles, Application and Specification
4.3.3 Genmab Bispecific Antibody Market Performance (2015-2020)
4.3.4 Genmab Business Overview
4.4 EMD Serono
4.4.1 EMD Serono Basic Information
4.4.2 Bispecific Antibody Product Profiles, Application and Specification
4.4.3 EMD Serono Bispecific Antibody Market Performance (2015-2020)
4.4.4 EMD Serono Business Overview
4.5 Regeneron Pharmaceuticals
4.5.1 Regeneron Pharmaceuticals Basic Information
4.5.2 Bispecific Antibody Product Profiles, Application and Specification
4.5.3 Regeneron Pharmaceuticals Bispecific Antibody Market Performance (2015-2020)
4.5.4 Regeneron Pharmaceuticals Business Overview
4.6 Roche
4.6.1 Roche Basic Information
4.6.2 Bispecific Antibody Product Profiles, Application and Specification
4.6.3 Roche Bispecific Antibody Market Performance (2015-2020)
4.6.4 Roche Business Overview
4.7 Chugai Pharmaceutical
4.7.1 Chugai Pharmaceutical Basic Information
4.7.2 Bispecific Antibody Product Profiles, Application and Specification
4.7.3 Chugai Pharmaceutical Bispecific Antibody Market Performance (2015-2020)
4.7.4 Chugai Pharmaceutical Business Overview
4.8 Sanofi
4.8.1 Sanofi Basic Information
4.8.2 Bispecific Antibody Product Profiles, Application and Specification
4.8.3 Sanofi Bispecific Antibody Market Performance (2015-2020)
4.8.4 Sanofi Business Overview
4.9 Immunomedics
4.9.1 Immunomedics Basic Information
4.9.2 Bispecific Antibody Product Profiles, Application and Specification
4.9.3 Immunomedics Bispecific Antibody Market Performance (2015-2020)
4.9.4 Immunomedics Business Overview
4.10 Neovii Biotech
4.10.1 Neovii Biotech Basic Information
4.10.2 Bispecific Antibody Product Profiles, Application and Specification
4.10.3 Neovii Biotech Bispecific Antibody Market Performance (2015-2020)
4.10.4 Neovii Biotech Business Overview
4.11 Eli Lilly
4.11.1 Eli Lilly Basic Information
4.11.2 Bispecific Antibody Product Profiles, Application and Specification
4.11.3 Eli Lilly Bispecific Antibody Market Performance (2015-2020)
4.11.4 Eli Lilly Business Overview
4.12 Amgen
4.12.1 Amgen Basic Information
4.12.2 Bispecific Antibody Product Profiles, Application and Specification
4.12.3 Amgen Bispecific Antibody Market Performance (2015-2020)
4.12.4 Amgen Business Overview
4.13 Pieris
4.13.1 Pieris Basic Information
4.13.2 Bispecific Antibody Product Profiles, Application and Specification
4.13.3 Pieris Bispecific Antibody Market Performance (2015-2020)
4.13.4 Pieris Business Overview
4.14 Merus
4.14.1 Merus Basic Information
4.14.2 Bispecific Antibody Product Profiles, Application and Specification
4.14.3 Merus Bispecific Antibody Market Performance (2015-2020)
4.14.4 Merus Business Overview
4.15 Ablynx
4.15.1 Ablynx Basic Information
4.15.2 Bispecific Antibody Product Profiles, Application and Specification
4.15.3 Ablynx Bispecific Antibody Market Performance (2015-2020)
4.15.4 Ablynx Business Overview
4.16 Genentech
4.16.1 Genentech Basic Information
4.16.2 Bispecific Antibody Product Profiles, Application and Specification
4.16.3 Genentech Bispecific Antibody Market Performance (2015-2020)
4.16.4 Genentech Business Overview
4.17 OncoMed Pharmaceuticals
4.17.1 OncoMed Pharmaceuticals Basic Information
4.17.2 Bispecific Antibody Product Profiles, Application and Specification
4.17.3 OncoMed Pharmaceuticals Bispecific Antibody Market Performance (2015-2020)
4.17.4 OncoMed Pharmaceuticals Business Overview
4.18 MacroGenics
4.18.1 MacroGenics Basic Information
4.18.2 Bispecific Antibody Product Profiles, Application and Specification
4.18.3 MacroGenics Bispecific Antibody Market Performance (2015-2020)
4.18.4 MacroGenics Business Overview
4.19 NovImmune SA
4.19.1 NovImmune SA Basic Information
4.19.2 Bispecific Antibody Product Profiles, Application and Specification
4.19.3 NovImmune SA Bispecific Antibody Market Performance (2015-2020)
4.19.4 NovImmune SA Business Overview
4.20 Adimab
4.20.1 Adimab Basic Information
4.20.2 Bispecific Antibody Product Profiles, Application and Specification
4.20.3 Adimab Bispecific Antibody Market Performance (2015-2020)
4.20.4 Adimab Business Overview
4.21 Emergent BioSolutions
4.21.1 Emergent BioSolutions Basic Information
4.21.2 Bispecific Antibody Product Profiles, Application and Specification
4.21.3 Emergent BioSolutions Bispecific Antibody Market Performance (2015-2020)
4.21.4 Emergent BioSolutions Business Overview
4.22 AstraZeneca (MedImmune)
4.22.1 AstraZeneca (MedImmune) Basic Information
4.22.2 Bispecific Antibody Product Profiles, Application and Specification
4.22.3 AstraZeneca (MedImmune) Bispecific Antibody Market Performance (2015-2020)
4.22.4 AstraZeneca (MedImmune) Business Overview

5 Global Bispecific Antibody Market Analysis by Regions

5.1 Global Bispecific Antibody Sales, Revenue and Market Share by Regions

5.1.1 Global Bispecific Antibody Sales by Regions (2015-2020)

5.1.2 Global Bispecific Antibody Revenue by Regions (2015-2020)

5.2 North America Bispecific Antibody Sales and Growth Rate (2015-2020)

5.3 Europe Bispecific Antibody Sales and Growth Rate (2015-2020)

5.4 Asia-Pacific Bispecific Antibody Sales and Growth Rate (2015-2020)

5.5 Middle East and Africa Bispecific Antibody Sales and Growth Rate (2015-2020)

5.6 South America Bispecific Antibody Sales and Growth Rate (2015-2020)

6 North America Bispecific Antibody Market Analysis by Countries

6.1 North America Bispecific Antibody Sales, Revenue and Market Share by Countries

6.1.1 North America Bispecific Antibody Sales by Countries (2015-2020)

6.1.2 North America Bispecific Antibody Revenue by Countries (2015-2020)

6.1.3 North America Bispecific Antibody Market Under COVID-19

6.2 United States Bispecific Antibody Sales and Growth Rate (2015-2020)

6.2.1 United States Bispecific Antibody Market Under COVID-19

6.3 Canada Bispecific Antibody Sales and Growth Rate (2015-2020)

6.4 Mexico Bispecific Antibody Sales and Growth Rate (2015-2020)

7 Europe Bispecific Antibody Market Analysis by Countries

7.1 Europe Bispecific Antibody Sales, Revenue and Market Share by Countries

7.1.1 Europe Bispecific Antibody Sales by Countries (2015-2020)

7.1.2 Europe Bispecific Antibody Revenue by Countries (2015-2020)

7.1.3 Europe Bispecific Antibody Market Under COVID-19

7.2 Germany Bispecific Antibody Sales and Growth Rate (2015-2020)

7.2.1 Germany Bispecific Antibody Market Under COVID-19

7.3 UK Bispecific Antibody Sales and Growth Rate (2015-2020)

7.3.1 UK Bispecific Antibody Market Under COVID-19

7.4 France Bispecific Antibody Sales and Growth Rate (2015-2020)

7.4.1 France Bispecific Antibody Market Under COVID-19

7.5 Italy Bispecific Antibody Sales and Growth Rate (2015-2020)

7.5.1 Italy Bispecific Antibody Market Under COVID-19

7.6 Spain Bispecific Antibody Sales and Growth Rate (2015-2020)

7.6.1 Spain Bispecific Antibody Market Under COVID-19

7.7 Russia Bispecific Antibody Sales and Growth Rate (2015-2020)

7.7.1 Russia Bispecific Antibody Market Under COVID-19

8 Asia-Pacific Bispecific Antibody Market Analysis by Countries

8.1 Asia-Pacific Bispecific Antibody Sales, Revenue and Market Share by Countries

8.1.1 Asia-Pacific Bispecific Antibody Sales by Countries (2015-2020)

8.1.2 Asia-Pacific Bispecific Antibody Revenue by Countries (2015-2020)

8.1.3 Asia-Pacific Bispecific Antibody Market Under COVID-19

8.2 China Bispecific Antibody Sales and Growth Rate (2015-2020)

8.2.1 China Bispecific Antibody Market Under COVID-19

8.3 Japan Bispecific Antibody Sales and Growth Rate (2015-2020)

8.3.1 Japan Bispecific Antibody Market Under COVID-19

8.4 South Korea Bispecific Antibody Sales and Growth Rate (2015-2020)

8.4.1 South Korea Bispecific Antibody Market Under COVID-19

8.5 Australia Bispecific Antibody Sales and Growth Rate (2015-2020)

8.6 India Bispecific Antibody Sales and Growth Rate (2015-2020)

8.6.1 India Bispecific Antibody Market Under COVID-19

8.7 Southeast Asia Bispecific Antibody Sales and Growth Rate (2015-2020)

8.7.1 Southeast Asia Bispecific Antibody Market Under COVID-19

9 Middle East and Africa Bispecific Antibody Market Analysis by Countries

9.1 Middle East and Africa Bispecific Antibody Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Bispecific Antibody Sales by Countries (2015-2020)

9.1.2 Middle East and Africa Bispecific Antibody Revenue by Countries (2015-2020)

9.1.3 Middle East and Africa Bispecific Antibody Market Under COVID-19

9.2 Saudi Arabia Bispecific Antibody Sales and Growth Rate (2015-2020)

9.3 UAE Bispecific Antibody Sales and Growth Rate (2015-2020)

9.4 Egypt Bispecific Antibody Sales and Growth Rate (2015-2020)

9.5 Nigeria Bispecific Antibody Sales and Growth Rate (2015-2020)

9.6 South Africa Bispecific Antibody Sales and Growth Rate (2015-2020)

10 South America Bispecific Antibody Market Analysis by Countries

10.1 South America Bispecific Antibody Sales, Revenue and Market Share by Countries

10.1.1 South America Bispecific Antibody Sales by Countries (2015-2020)

10.1.2 South America Bispecific Antibody Revenue by Countries (2015-2020)

10.1.3 South America Bispecific Antibody Market Under COVID-19

10.2 Brazil Bispecific Antibody Sales and Growth Rate (2015-2020)

10.2.1 Brazil Bispecific Antibody Market Under COVID-19

10.3 Argentina Bispecific Antibody Sales and Growth Rate (2015-2020)

10.4 Columbia Bispecific Antibody Sales and Growth Rate (2015-2020)

10.5 Chile Bispecific Antibody Sales and Growth Rate (2015-2020)

11 Global Bispecific Antibody Market Segment by Types

11.1 Global Bispecific Antibody Sales, Revenue and Market Share by Types (2015-2020)

11.1.1 Global Bispecific Antibody Sales and Market Share by Types (2015-2020)

11.1.2 Global Bispecific Antibody Revenue and Market Share by Types (2015-2020)

11.2 Catumaxomab (Removab) Sales and Price (2015-2020)
11.3 Blinatumomab Sales and Price (2015-2020)
11.4 Duligotumab Sales and Price (2015-2020)
11.5 SAR 156597 Sales and Price (2015-2020)

12 Global Bispecific Antibody Market Segment by Applications

12.1 Global Bispecific Antibody Sales, Revenue and Market Share by Applications (2015-2020)

12.1.1 Global Bispecific Antibody Sales and Market Share by Applications (2015-2020)

12.1.2 Global Bispecific Antibody Revenue and Market Share by Applications (2015-2020)

12.2 BsMAb for Diagnosis of Infectious Diseases Sales, Revenue and Growth Rate (2015-2020)
12.3 Diagnosis of Bacterial Infections Sales, Revenue and Growth Rate (2015-2020)
12.4 Diagnosis of Viral Infections Sales, Revenue and Growth Rate (2015-2020)
12.5 BsMAb for Cancer Diagnostic Sales, Revenue and Growth Rate (2015-2020)
12.6 BsAbs Blocking Signaling Pathways Sales, Revenue and Growth Rate (2015-2020)
12.7 BsAbs Targeting Tumor Angiogenesis Sales, Revenue and Growth Rate (2015-2020)
12.8 Specific Delivery of Effector Compounds to Targets Sales, Revenue and Growth Rate (2015-2020)
12.9 Bispecific Antibodies & Gene Therapy Sales, Revenue and Growth Rate (2015-2020)

13 Bispecific Antibody Market Forecast by Regions (2020-2026)

13.1 Global Bispecific Antibody Sales, Revenue and Growth Rate (2020-2026)

13.2 Bispecific Antibody Market Forecast by Regions (2020-2026)

13.2.1 North America Bispecific Antibody Market Forecast (2020-2026)

13.2.2 Europe Bispecific Antibody Market Forecast (2020-2026)

13.2.3 Asia-Pacific Bispecific Antibody Market Forecast (2020-2026)

13.2.4 Middle East and Africa Bispecific Antibody Market Forecast (2020-2026)

13.2.5 South America Bispecific Antibody Market Forecast (2020-2026)

13.3 Bispecific Antibody Market Forecast by Types (2020-2026)

13.4 Bispecific Antibody Market Forecast by Applications (2020-2026)

13.5 Bispecific Antibody Market Forecast Under COVID-19

14 Appendix

14.1 Methodology

14.2 Research Data Source

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology
Mizuno Corp
AutoX
A.JAFFE
Aaga Marketing
AGRIC SA
Alcimed
AMSEC
Aquanova
AYTB Industrial
Bain & Company
Brooks Life Sciences
Cirona Labs
CMV Informatics
CONNEMARAORGANIC SEAWEED COMPANY
Desmet Ballestra Group
Dine4Fit, a.s.
Dream Incubator Vietnam Joint Stock Company
DSM
Eastman Chemical
Edwards Vacuum
Emerson
Getinge
Hello Flexibles
Industrie Beteiligungs Gesellschaft IBG
Inscripta, Inc.
JLL Technologies
Kari-Out
Marafie Engineering Co
Monitor Deloitte
Mossif3
mpumalanga stainless initiative
Nextteq, LLC
Pattern
Phizzle
Phronesis Partners Pte. Ltd.
PSP Specialties
Reno Refractories, Inc.
Roche Diagnostics International Ltd.
Rockfield Medical Device
RSG Media
Sealed Air
Sutton Capital Partners, Inc
Tenshi LifeCare Pvt Ltd (Velbiom Probiotics PVt Ltd)
The Crocodile Integrated Marketing Ltd
Tomorrow.io
UL
Vibrant Marketing
Wild Republic
ams OSRAM
Atelerix Life Sciences Inc
Beckman Coulter Life Sciences
BIOTECH VISION CARE PVT. LTD
Chiripal
Circle NVI
Freudenberg Filtration Technologies SE & Co. KG
FTA HSRP Solutions Pvt Ltd
Goetz Partners
Good clean love
Hasso Plattner d-school at UCT
InnoFaith Beauty Sciences
INSALA
Kukuza Consulting
MilliporeSigma
Panasonic Industry Europe
Quintus Technologies
Renesas
Roche Diagnostics International Ltd.
Timee, Inc.
YCP Solidiance
Graffer
Magnus
Pantex Ennerflo
The Japan Association of Bonded Magnetic Materials
SIS
Elian
RS Connect
3 Hunters Talent Solutions LATAM
Atelerix Life Sciences Inc
David Clark
DSGLOBAL CO.,LTD.
Hitotsubashi University
kovis-group
Saunacore
Suez Consulting
WestRock
Medeon Biodesign
Power Transmission Consulting, PTC AB
Sint Maartenskliniek
ITW Specialty Films
American Fuji Seal, Inc.
Tag-consultants.com
HAZEMAG Systems GmbH
Dabur International
lippert componentrs
Aelea Commodities Private Limited
ERRIA A/S
Chiripal Group
Capstone Partners
VETTEX SRL
Ægir Advisory Services
John Deere
ADTEC Plasma Technology
Cairneagle
Mckinsey
Panasonic Consumer Electronics Company
ACT
Mele & Co
SAZKA a.s.
THIN
Assurance Services International
Intro-act Inc
School of Health Sciences/Democritus University of Thrace
W.L.Gore
Nippon Steel Co.
AFB International
986 Labs
Bamboi
Zaptin Communications LLC
DONGIL MACHINERY
GABALabs
Salon IQ
SW Umwelttechnik Stoiser & Wolschner AG
RSM Dahman Auditors
DentalMonitoring
Emosis Diagnostics
 CDA InterCorp
Lanhe USA, Inc
SMP
Vibes
Tenshi Life Sciences
Simac Masic
CedarBridge
FedEx Express
Chonnam National University
GE Renewable Energy
Crosby Group
Molecular Health
Bauerfeind
TPE HEALTHCARE SDN. BHD.
3 Digity
PHC Holdings Corporation

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005